相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls
K. Koehler-Forsberg et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression
C. N. Haile et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression
Paulo R. Shiroma et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
James W. Murrough et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Inhibition of Glycine Transporter-I as a Novel Mechanism for the Treatment of Depression
Chih-Chia Huang et al.
BIOLOGICAL PSYCHIATRY (2013)
A Randomized Trial of a Low-Trapping Nonselective N-Methyl-D-Aspartate Channel Blocker in Major Depression
Carlos A. Zarate et al.
BIOLOGICAL PSYCHIATRY (2013)
Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
James W. Murrough et al.
BIOLOGICAL PSYCHIATRY (2013)
A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression
Uriel Heresco-Levy et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression
Diogo R. Lara et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Daily Oral Ketamine for the Treatment of Depression and Anxiety in Patients Receiving Hospice Care: A 28-Day Open-Label Proof-of-Concept Trial
Scott A. Irwin et al.
JOURNAL OF PALLIATIVE MEDICINE (2013)
Serial infusions of low-dose ketamine for major depression
Keith G. Rasmussen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Ketamine for Depression: Where Do We Go from Here?
Marije Aan Het Rot et al.
BIOLOGICAL PSYCHIATRY (2012)
Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
Carlos A. Zarate et al.
BIOLOGICAL PSYCHIATRY (2012)
Ketamine as a Novel Antidepressant: From Synapse to Behavior
J. W. Murrough
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Ketamine for Treatment-Resistant Unipolar Depression Current Evidence
Sanjay J. Mathew et al.
CNS DRUGS (2012)
Reduced Metabotropic Glutamate Receptor 5 Density in Major Depression Determined by [11C]ABP688 PET and Postmortem Study
Alexandra Deschwanden et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study
H. J. Conradi et al.
PSYCHOLOGICAL MEDICINE (2011)
Interpretation of random effects meta-analyses
Richard D. Riley et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
Nancy Diazgranados et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
Marije aan het Rot et al.
BIOLOGICAL PSYCHIATRY (2010)
Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials
John R. Geddes et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Global Brain Gene Expression Analysis Links Glutamatergic and GABAergic Alterations to Suicide and Major Depression
Adolfo Sequeira et al.
PLOS ONE (2009)
Glutamate-based antidepressants: 20 years on
Phil Skolnick et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Gerard Sanacora et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Functional impairment in the remission phase of bipolar disorder
A Fagiolini et al.
BIPOLAR DISORDERS (2005)
An open-label trial of riluzole in patients with treatment-resistant major depression
CA Zarate et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Post-randomisation exclusions:: the intention to treat principle and excluding patients from analysis
D Fergusson et al.
BMJ-BRITISH MEDICAL JOURNAL (2002)
Small-dose ketamine improves the postoperative state of depressed patients
A Kudoh et al.
ANESTHESIA AND ANALGESIA (2002)
Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes
JJ Deeks
STATISTICS IN MEDICINE (2002)
Molecular abnormalities in the major psychiatric illnesses: Classification and Regression Tree (CRT) analysis of post-mortem prefrontal markers
MB Knable et al.
MOLECULAR PSYCHIATRY (2002)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)